|
Scl 70 |
Scl 70 |
Scl 70 |
ACA |
ACA |
ACA |
RNAPIII |
RNAPIII |
RNAPIII |
|
positive
n=41
|
negative
n=59
|
p
|
positive
n=27
|
negative
n=73
|
p
|
positive
n=15
|
negative
n=85
|
p
|
lcSSc |
15 (36.6%) |
48 (81.4%) |
<0.001 |
27 (100%) |
36
(49.3%) |
<0.001 |
5 (33.3%) |
58 (68.2%) |
0.027 |
Female |
38 (92.7%) |
49 (83.1%) |
0.229 |
26 (96.3) |
61 (83.6%) |
0.177 |
11 (73.3%) |
76 (89.4%) |
0.103 |
ILD |
24 (58.5) |
9 (15.3%) |
<0.001 |
1 (3.7%) |
32
(43.8%) |
<0.001 |
9 (60%) |
24 (28.2%) |
0.016 |
PAH |
1 (2.4%) |
2 (3.4%) |
1.000 |
0 |
3 (4.1%) |
0.561 |
2 (13.3%) |
1 (1.2%) |
0.058 |
Malignancy |
0 |
3 (5.1%) |
0.267 |
0 |
3 (4.1%) |
0.561 |
2 (13.3%) |
1 (1.2%) |
0.058 |
DU |
4 (9.8%) |
9 (15.3%) |
0.551 |
4 (14.8%) |
9 (12.3%) |
0.743 |
2 (13.3%) |
11 (12.9%) |
1.000 |
GIS |
24 (58.5%) |
36 (61%) |
0.803 |
15 (55.6%) |
45 (61.6%) |
0.581 |
11 (73.3%) |
49 (57.6%) |
0.392 |
Overlap |
5 (12.2%) |
19 (32.2%) |
0.021 |
11 (40.7) |
13 (17.8%) |
0.017 |
1 (6.7%) |
23 (27.1%) |
0.110 |
Age |
46.9±12.7 |
51±11.8 |
0.210 |
50.4±10.3 |
48.4±12.9 |
0.602 |
55.3±8.5 |
47.7±12.5 |
0.026 |
Disease duration |
2.03±1.5 |
2.14±1.3 |
0.471 |
2±1.4 |
2.13±1.4 |
0.770 |
2.6±1.6 |
2±1.3 |
0.162 |
mRSS |
14.3±11.5 |
8.6±9 |
0.002 |
6.5±5.2 |
12.5±11.4 |
0.024 |
20.4±13.8 |
9.2±8.6 |
0.001 |